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Helicobacter pylori VacA Suppresses Lactobacillus acidophilus-Induced
Interferon Beta Signaling in Macrophages via Alterations in the
Endocytic Pathway
Gudrun Weiss,a,b Sam Forster,a Aaron Irving,c Michelle Tate,a Richard L. Ferrero,a Paul Hertzog,a Hanne Frøkiær,b
Maria Kaparakis-Liaskosa
Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Monash University, Clayton, Australiaa; Department of Veterinary Disease
Biology, Molecular Immunology, Copenhagen University, Frederiksberg, Denmarkb; Centre for Cancer Research, Monash Institute of Medical Research, Clayton, Australiac
H.F. and M.K.-L. contributed equally to this work.
ABSTRACT Helicobacter pylori causes chronic gastritis and avoids elimination by the immune system of the infected host. The
commensal bacterium Lactobacillus acidophilus has been suggested to exert beneficial effects as a supplement duringH. pylori
eradication therapy. In the present study, we applied whole-genomemicroarray analysis to compare the immune responses in-
duced in murine bone marrow-derived macrophages (BMDMs) stimulated with L. acidophilus,H. pylori, or both bacteria in
combination. While L. acidophilus induced a Th1-polarizing response characterized by high expression of interferon beta
(IFN-) and interleukin 12 (IL-12),H. pylori strongly induced the innate cytokines IL-1 and IL-1. In BMDMs prestimulated
with L. acidophilus,H. pylori blocked the expression of L. acidophilus-induced IFN- and IL-12 and suppressed the expression
of key regulators of the Rho, Rac, and Cdc42 GTPases. The inhibition of L. acidophilus-induced IFN- was independent ofH. py-
lori viability and the virulence factor CagPAI; however, a vacuolating cytotoxin (vacA) mutant was unable to block IFN-. Con-
focal microscopy demonstrated that the addition ofH. pylori to L. acidophilus-stimulated BMDMs redirects intracellular pro-
cessing, leading to an accumulation of L. acidophilus in the endosomal and lysosomal compartments. Thus, our findings
indicate thatH. pylori inhibits the development of a strong Th1-polarizing response in BMDMs stimulated with L. acidophilus
by blocking the production of IFN- in a VacA-dependent manner. We suggest that this abrogation is caused by a redirection of
the endocytotic pathway in the processing of L. acidophilus.
IMPORTANCE Approximately half of the world’s population is infected withHelicobacter pylori. The factors that allow this patho-
gen to persist in the stomach and cause chronic infections have not yet been fully elucidated. In particular, howH. pylori avoids
killing by macrophages, one of the main types of immune cell underlying the epithelium, remains elusive. Here we have shown
that theH. pylori virulence factor VacA plays a key role by blocking the activation of innate cytokines induced by the probiotic
Lactobacillus acidophilus in macrophages and suppresses the expression of key regulators required for the organization and dy-
namics of the intracellular cytoskeleton. Our results identify potential targets for the treatment ofH. pylori infection and vacci-
nation, since specific inhibition of the toxin VacA possibly allows the activation of an efficient immune response and thereby
eradication ofH. pylori in the host.
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The Gram-negative bacterium Helicobacter pylori colonizes thehuman stomach and has infected more than half of the world’s
population (1, 2). Upon infection, H. pylori activates an inflam-
matory response which leads to the recruitment of macrophages,
neutrophils, and lymphocytes to the gastric tissue (3). Macro-
phages can efficiently engulf H. pylori; however, this pathogenic
bacterium has developed mechanisms to avoid killing upon
phagocytosis and prevents the induction of an adaptive immune
response (4–7). It is likely that the failure of macrophages to elim-
inate H. pylori contributes to bacterial persistence in the host and
thereby to the development of chronic infection. Indeed, we have
previously reported the requirement for macrophages in the de-
velopment of H. pylori-induced gastritis in vivo (8).
It is currently not fully understood how H. pylori avoids elim-
ination by the immune system and is able to survive and persist in
human macrophages. Several different mechanisms have been
suggested based on the virulence factors expressed byH. pylori (9).
H. pylori retards its own uptake by phagocytes, which has been
suggested to be dependent on type IV secretion components en-
coded by the cytotoxin-associated gene pathogenicity island (Cag-
PAI) (10, 11), one of the main pathogenic factors in H. pylori
infection (12). Once it is intracellular, H. pylori actively delays
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actin polymerization and phagosome formation in addition to
disrupting membrane trafficking in macrophages (5).
H. pylori has been indicated to utilize several virulence factors
facilitating the escape of intracellular degradation in phagocytes.
Upon uptake in macrophages, H. pylori initially localizes in
phagosomes that coalesce into “megasomes” containing multiple
bacteria (5, 13), which has been proposed to cause resistance to
intracellular killing (5). A study by Zheng and coworkers sug-
gested that retention of TACO, a tryptophan aspartate-containing
coat protein on phagosomes, impairs fusion of phagosomes and
lysosomes in macrophages infected with H. pylori (7).
It has been reported that probiotic supplementation to H. py-
lori eradication therapy increases tolerability and decreases side
effects (14–16), but the results are contradictory (17). We have
previously shown that the probiotic bacterium Lactobacillus aci-
dophilus NCFM is a strong inducer of the Th1-polarizing cyto-
kines interferon beta (IFN-) and interleukin 12 (IL-12) in den-
dritic cells (18–20). In this study, we investigated whether
L. acidophilus is able to modulate the inflammatory response in-
duced by H. pylori in bone marrow-derived macrophages
(BMDMs). We utilized whole-genome microarray analysis to
identify the cellular and molecular mechanisms involved in up-
take and processing of the bacteria in addition to the immune
response generated. BMDMs were stimulated with either L. acido-
philus or H. pylori or with both bacteria in combination. Contrary
to our expectations, our results demonstrate that H. pylori is able
to block the induction of IFN- and IL-12 by L. acidophilus. Fur-
thermore,Rgs1/2, Fgd2, andDock8, key regulators of the Rho, Rac,
and Cdc42 GTPases, respectively, required for the organization
and dynamics of the actin cytoskeleton, were strongly suppressed
when H. pylori was added to BMDMs prestimulated with L. aci-
dophilus. This inhibition was independent of the viability ofH. py-
lori or the virulence factor CagPAI but completely dependent on
the VacA toxin. Confocal microscopy revealed that the addition of
H. pylori to L. acidophilus-treated BMDMs induces alterations in
the endocytic pathway that prevent intracellular processing of
L. acidophilus and thereby the induction of IFN-. Thus, H. pylori
is able to prevent the activation of innate cytokines that can mod-
FIG 1 H. pylori modulates the stimulatory profile induced by L. acidophilus in murine bone marrow-derived macrophages. Murine BMDMs from three
individual mice were stimulated for 5 h with either L. acidophilus NCFM or H. pylori 251 or prestimulated with L. acidophilus NCFM for 1 h prior to the addition
of Helicobacter pylori 251. (A) Venn diagram illustrating pairwise overlap of differentially expressed genes (P 0.01; fold change greater than2) by one-way
ANOVA with Benjamini-Hochberg multiple testing correction. (B) Heat map of differentially expressed genes (P  0.01, fold change greater than 1.5)
expressed at a lower or higher rate than with L. acidophilus treatment. Blue designates genes expressed at a lower level than with L. acidophilus alone, while red
indicates greater expression. Data were classified using hierarchical clustering by genes with Euclidean distances and centroid linkage rules.
Weiss et al.
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ulate the adaptive immune response in macrophages via the viru-
lence factor VacA, which possibly allows persistence and limited
eradication in the host.
RESULTS
H. pylorimodulates the stimulatory profile induced by L. acido-
philus in murine bone marrow-derived macrophages. To com-
pare the gene expression profiles after stimulation with L. acido-
philus and H. pylori, murine bone marrow-derived macrophages
(BMDMs) were stimulated either with L. acidophilus NCFM or
with an H. pylori clinical isolate, strain 251, or with both bacteria
in combination. Since we wanted to ensure that L. acidophilus is
able to interact with the macrophages prior to their encounter
with the motile pathogen H. pylori, we added H. pylori 251 to
BMDMs after 1 h of prestimulation with L. acidophilus NCFM
(cell-bacterium ratio, 1:1). After 5 h, the BMDMs were harvested
and genome-wide microarray analysis was performed. In total,
4,181 upregulated and 3,956 downregulated genes were common
in the three groups of stimulatory conditions (Fig. 1A). In the
L. acidophilus-stimulated group, 153 genes were exclusively up-
regulated and 109 genes exclusively downregulated. Upon stimu-
lation with H. pylori alone, 61 genes were exclusively upregulated
and 70 genes exclusively downregulated. With both strains in
combination, only 2 genes were exclusively upregulated and 22
genes exclusively downregulated. The two groups of BMDMs
stimulated with either L. acidophilus or H. pylori alone had 22
upregulated and 2 downregulated genes in common. In contrast,
for L. acidophilus stimulation, there were 70 upregulated and 61
downregulated genes, and for H. pylori, there were 109 upregu-
lated and 153 downregulated genes, in common with the BMDMs
that were stimulated with both bacteria.
The top 20 most strongly upregulated genes in BMDMs stim-
ulated with L. acidophilus or H. pylori are listed in Table S1 and
Table S2 in the supplemental material, respectively. Analysis of the
genes expressed revealed that L. acidophilus strongly induced in-
nate response genes that promote the development of an adaptive
immune response, characterized by IL-12 and IFN- and the
chemokines Cxcl10 and Cxcl11, known to be involved in recruit-
ment of activated T cells to the site of infection (Table S1). In
contrast, H. pylori induced primarily an innate immune response
upregulating the cytokines IL-1 (Il1b) and IL-1 (Il1a) and the
neutrophil-recruiting chemokines (Cxcl3, Cxcl1, and Cxcl2) (see
Table S2). Notably, H. pylori strongly induced serum amyloid A 3
(Saa3), an acute-phase reactant elevated in chronic low-grade in-
flammation (21), and Socs3 (suppressor of cytokine signaling 3), a
negative regulator of cytokine signaling (22). Figure S1 illustrates
a heat map of the genes differentially expressed upon addition of
H. pylori, L. acidophilus, or both strains in combination compared
to expression in nonstimulated cells (P  0.01; fold change of
greater than 2). Figure 1B displays the downregulated genes
(blue color) and upregulated genes (red color) induced by L. aci-
dophilus, H. pylori, or both strains in combination compared to
L. acidophilus alone (P  0.01; fold change of greater than 2).
Blue designates genes expressed at a lower level than with L. aci-
dophilus alone, while red indicates greater expression.
Table 1 and Fig. 1B present genes that were either strongly
induced or suppressed upon the addition of both L. acidophilus
and H. pylori to BMDMs relative to results with L. acidophilus
alone. Only two genes were strongly induced: P2rx2 (purinergic
receptor P2X, ligand-gated ion channel 2) and Pdxp (pyridoxal
[pyridoxine, vitamin B6] phosphatase), both regulators of actin
cytoskeleton dynamics, were upregulated 7.7-fold and 3.9-fold,
respectively. P2rx2 belongs to the family of ligand-gated ion chan-
nels that open in response to ATP (23). Activation of P2X recep-
tors induces actin cytoskeleton alterations via Rho activation in
macrophages (24, 25). Pdxp is located in the cytosol, colocalizes
with the actin cytoskeleton, and acts as a positive regulator of actin
filament depolymerization (26). In total, 12 genes were strongly
suppressed (Table 1). The gene encoding IFN- (Ifnb) was the
most significantly inhibited (18.5-fold) over 41,000 genes and
transcripts analyzed. Interleukin 12b (encoded by Il12b) was like-
wise significantly suppressed (4.3-fold). Other strongly sup-
pressed genes identified were Rgs2 and Rgs1 (regulator of
G-protein signalling 2 and 1) (27),Dock8 (dedicator of cytokinesis
8) (28), and Fgd2 (FYVE, RhoGEF, and PH domain-containing 2)
(29), all involved in signaling of Rho, Rac, or Cdc42 GTPase,
which are key regulators of the actin cytoskeleton (P 0.01) (30).
H. pyloriblocks production of L. acidophilus-induced IFN-
and IL-12 in murine bone marrow-derived macrophages. Our
microanalysis data revealed that genes encoding the cytokines
IFN- and IL-12 were strongly inhibited upon the addition of
H. pylori to BMDMs prestimulated with L. acidophilus (Table 1),
TABLE 1 Strongest induced/suppressed genes in BMDMs stimulated with L. acidophilus and H. pylori in combination
Probe name Annotation
Fold change
DescriptionInduced Suppressed
A_51_P498526 P2rx2 7.68 Purinergic receptor P2X, ligand-gated ion channel 2
A_52_P609120 Pdxp 3.90 Pyridoxal (pyridoxine, vitamin B6) phosphatase
A_51_P144180 Ifnb 18.47 Interferon beta 1
A_51_P419768 Rgs2 11.13 Regulator of G-protein signalling 2
A_51_P478556 Cited2 10.42 Cbp/p300-interacting transactivator 2
A_51_P306017 Dll1 8.73 Delta-like 1
A_51_P455326 Sele 7.97 Selectin, endothelial cell
A_51_P315904 Gadd45g 4.46 Growth arrest and DNA-damage-inducible 45 gamma
A_51_P260683 Rgsl 4.43 Regulator of G-protein signaling 1
A_51_P385812 1112b 4.29 lnterleukin 12b
A_51_P367866 Egrl 4.23 Early growth response 1
A_51_P149349 Nfxl1 3.72 Nuclear transcription factor, X-box binding-like 1
A_51_P484718 Dock8 3.71 Dedicator of cytokinesis 8
A_52_P260994 Fgd2 3.66 FYVE, RhoGEF and PH domain containing 2
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hence altering the effect of L. acidophilus. To confirm this,
BMDMs were stimulated with either L. acidophilus NCFM or
H. pylori 251 or pretreated with L. acidophilus NCFM for 1 h prior
to the addition of H. pylori 251. The levels of the IFN- and IL-12
proteins were determined in the superna-
tants after 10 h of stimulation (Fig. 2A).
L. acidophilus induced high expression of
IFN- (840 pg/ml) and IL-12 (10,700 pg/
ml), whereas H. pylori 251 induced small
amounts of IFN- and IL-12 (20 pg/ml
and 850 pg/ml, respectively). As expected,
the addition of H. pylori to BMDMs pre-
stimulated with L. acidophilus signifi-
cantly suppressed the release of IFN- by
90% and that of IL-12 by 66% (*, P 
0.01).
To determine whether this inhibition
is time dependent, the gene expression of
Ifn- and Il-12 was analyzed by reverse
transcription-PCR (RT-PCR) after 2, 4, 6,
and 8 h of stimulation (Fig. 2B). After 4 h,
the expression of Ifn- in the L. acidophi-
lus-stimulated BMDMs reached a maxi-
mum of 400-fold, whereas H. pylori in-
duced Ifn- only 15-fold compared to
results for controls. However, when
H. pyloriwas added to BMDMs prestimu-
lated with L. acidophilus, the expression of
Ifn-was completely blocked, and the ex-
pression of Il-12 was strongly reduced (by
94%) at all time points compared to re-
sults for BMDMs stimulated with L. aci-
dophilus alone (*, P  0.01), indicating
that the inhibitory effect is exerted at a
very early stage.
In all of our previous experiments, we
added both L. acidophilus and H. pylori at
a multiplicity of infection (MOI) of 1:1 to
the BMDMs. We next sought to investi-
gate the potency of H. pylori to block the
expression of Ifn- and addedH. pylori to
L. acidophilus-stimulated cells at MOIs of
1:2, 1:4, 1:8, and 1:16 (H. pylori-cell ratio)
(Fig. 2C). Even at an MOI as low as 1:8,
H. pylori was still able to significantly
downregulate the L. acidophilus-induced
Ifn- expression by 51% (*, P  0.01).
Only at an MOI of 1:16 the inhibition of
Ifn- was no longer significant. A similar
effect was observed when the expression
of Il-12 was measured. Since H. pylori is
able to suppress the induction of Ifn-
and Il-12 at a very low MOI, it is indicated
that this inhibitory effect is not restricted
to the action of an individual bacterium
but rather to a virulence determinant se-
creted by H. pylori.
Next, we aimed to determine the time
point at which H. pylori is no longer able
to suppress the induction of Ifn- and
Il-12 by L. acidophilus (Fig. 2D). At a preincubation time of 1.5 h
withL. acidophilus,H. pylori 251 significantly inhibited the expres-
sion of Ifn- by 92%, at 2 h by 83%, and at 2.5 h by 63%, compared
to results for BMDMs stimulated with L. acidophilus alone (*, P
FIG 2 H. pylori 251 blocks the induction of IFN- and IL-12 in murine bone marrow-derived
macrophages stimulated with L. acidophilus. BMDMs were stimulated with either L. acidophilusNCFM
or H. pylori 251 or prestimulated with L. acidophilus NCFM for 1 h prior to addition of Helicobacter
pylori 251. (A) IFN- and IL-12 were measured by ELISA in supernatants after 10 h of stimulation
(L. acidophilus NCFM plus H. pylori 251 versus L. acidophilus NCFM alone; *, P  0.01). Unstim.,
unstimulated. (B) RNA was extracted after 2, 4, 6, or 8 h of stimulation, cDNA was synthesized, and the
expression of Ifn- and Il-12 was analyzed by RT-PCR (L. acidophilus NCFM plus H. pylori 251 versus
L. acidophilus NCFM alone; *, P 0.01). (C) H. pylori 251 was added at various MOI (1:1, 1:2, 1:4, 1:8,
and 1:16, H. pylori/BMDM ratio) to BMDMs prestimulated with L. acidophilus (1 h). RNA was ex-
tracted after 4 h, cDNA was synthesized, and the expression of Ifn- and Il-12was analyzed by RT-PCR.
(D) BMDMs were prestimulated with L. acidophilus (L. acid. pre-incub.) for 1 h, 1.5 h, 2 h, 2.5 h, and
3.5 h prior to addition of H. pylori 251, RNA was extracted after 4 h, cDNA was synthesized, and the
expression of Ifn- and Il-12 was analyzed by RT-PCR (L. acidophilus NCFM plus H. pylori 251 versus
L. acidophilus NCFM alone; *, P 0.01). Data are means and SD for triplicate cultures and are repre-
sentative of three independent experiments.
Weiss et al.
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0.01). However, a downregulation of Ifn- was no longer evident
after 3.5 h of stimulation with L. acidophilus prior to addition of
H. pylori 251. A similar but less-pronounced inhibitory effect was
observed when the expression of Il-12 was measured, since signif-
icant suppression was evident only until the L. acidophilus prein-
cubation time of 2 h prior to addition of H. pylori 251 (*, P 
0.01). Thus, our results suggest that H. pylori-mediated inhibition
of Ifn- and Il-12 responses takes place after endocytosis and that
cellular uptake and processing of L. acidophilus may be required
for an induction of IFN- and IL-12.
We then aimed to confirm this inhibitory effect on other cyto-
kines and chemokines using RT-PCR. Expression levels of the T
cell- and macrophage-recruiting chemokine gene Cxcl10, as well
as those of the proinflammatory cytokine genes Tnf- and IL-1b,
were analyzed after 4 h (see Fig. S2 in the supplemental material).
Our results show that the addition of H. pylori 251 to BMDMs
preincubated with L. acidophilus is able to significantly downregu-
late the expression of Cxcl10 and Tnf- (*, P  0.01). However,
the expression of IL-1was significantly upregulated by the addi-
tion of H. pylori 251 to BMDMs preincubated with L. acidophilus
compared to results with L. acidophilus alone (*, P 0.01), which
is in accordance with our microarray results. Thus, we hereby
demonstrate that H. pylori is able to inhibit the activation of cyto-
kines that modulate an adaptive immune response but has an
additive effect on IL-1 when added to BMDMs prestimulated
with L. acidophilus.
Inhibition of IFN- by H. pylori is independent of viability
and the virulence factor CagPAI but dependent on the toxin
VacA. To establish the role of the virulence factor CagPAI in
blocking the expression of IFN-, we added isogenic H. pylori 251
CagPAI mutant bacteria to BMDMs preincubated with L. acido-
philus and measured the gene expression of Ifn- after 4 h
(Fig. 3A). The H. pylori 251 CagPAI mutant inhibited Ifn- ex-
pression in BMDMs preincubated with L. acidophilus to a level
equivalent to that of the wild-type H. pylori 251 strain, indicating
that the inhibitory effect is independent of CagPAI. To determine
whether bacterial viability is essential, we added heat-killed (HK)
H. pylori 251 and HK 251 CagPAI mutant to BMDMs prestimu-
lated with L. acidophilus and measured the level of IFN- in the
supernatants (Fig. 3B). Both HK H. pylori strains were capable of
significantly blocking L. acidophilus-induced IFN- (*, P 0.01).
Hence, our findings suggest that the inhibitory effect of H. pylori
on IFN- expression in L. acidophilus-stimulated BMDMs is de-
pendent neither on bacterial viability nor on the presence of
CagPAI.
Our microarray analysis revealed that key regulators of the
Rho, Rac, and Cdc42 GTPases are strongly suppressed upon stim-
ulation of BMDMs with L. acidophilus and H. pylori in combina-
tion. Entry of the H. pylori VacA toxin into epithelial cells is de-
pendent on pinocytosis and controlled by the Cdc42 GTPase (31).
Furthermore, in epithelial cells, VacA utilizes the Rac1 GTPase to
induce cell vacuolation in host cells (32). We therefore speculated
that the H. pylori VacA toxin may also play a role in macrophages
and may be implicated in the inhibition of Ifn- (Fig. 3C). Our
hypothesis was confirmed, since an isogenic H. pylori 251 vacA
mutant, in contrast to the wild-type strain, was unable to block
Ifn-when added to BMDMs prestimulated with L. acidophilus (P
 0.01). To recapitulate that VacA is essential for the immuno-
suppression of L. acidophilus-induced IFN-, we added bacterial-
free supernatants (SN) from wild-type H. pylori 251 in various
dilutions to BMDMs prestimulated with L. acidophilus (see
Fig. S3A in the supplemental material). Our finding was con-
firmed, since the VacA-containing supernatant from wild-type
H. pylori 251 strongly inhibited the IFN- response induced by
L. acidophilus. In contrast, bacterial-free supernatant from the
H. pylori 251 vacA mutant was not capable of suppressing IFN-
produced by L. acidophilus-stimulated macrophages (see
Fig. S3B).
In epithelial cells, VacA is known to disrupt vesicular traffick-
ing due to formation of anion-selective channels in the mem-
branes of late endocytic compartments (33). We therefore sought
to determine whether a similar mechanism is employed in mac-
FIG 3 Inhibition of IFN- by H. pylori is independent of viability and the virulence factor CagPAI but dependent on the toxin VacA. (A) BMDMs were
stimulated with L. acidophilus NCFM, H. pylori 251, or the H. pylori 251 CagPAI mutant alone or prestimulated with L. acidophilus NCFM (L. acid.) for 1 h prior
to addition of H. pylori strains. RNA was extracted after 4 h, cDNA was synthesized, and the expression of Ifn-was measured by RT-PCR (L. acidophilus NCFM
plus H. pylori 251 or plus the H. pylori 251 CagPAI mutant versus L. acidophilus NCFM alone; *, P 0.01). (B) BMDMs were prestimulated with L. acidophilus
NCFM for 1 h prior to addition of heat-killed (HK)H. pylori 251 and heat-killedH. pylori 251 CagPAI mutant. IFN-was measured in the supernatants 10 h after
stimulation by ELISA (L. acidophilus NCFM [L. acidoph.] plus HK H. pylori 251 or plus the H. pylori 251 CagPAI mutant versus L. acidophilus NCFM alone; *,
P  0.01). (C) BMDMs were prestimulated with L. acidophilus NCFM for 1 h prior to addition of H. pylori 251 or the H. pylori 251 vacA mutant. RNA was
extracted after 4 h, cDNA was synthesized, and the expression of Ifn-was measured by RT-PCR (L. acidophilusNCFM plus theH. pylori 251 vacAmutant versus
L. acidophilus NCFM alone; *, P  0.01). (D) BMDMs were preincubated for 30 min with the endosomal acidification blockers chloroquine (CQ) (final
concentration, 20 M) and bafilomycin A1 (Baf A1) (final concentration, 25 M) prior to stimulation with L. acidophilus NCFM. IFN- was measured in the
supernatants 10 h after stimulation by ELISA (L. acidophilus NCFM plus inhibitors versus L. acidophilus NCFM alone; *, P 0.01). Represented are the means
 SEM for triplicate macrophage cultures, which are representative of three independent experiments.
H. pylori Suppresses IFN- Induced by L. acidophilus
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rophages and whether phagosomal processing of L. acidophilus is
necessary for the induction of IFN-. BMDMs were preincubated
for 30 min with the endosomal acidification blockers chloroquine
and bafilomycin A1 prior to stimulation with L. acidophilus
(Fig. 3D). Viability of the cells was verified via trypan blue staining
(data not shown). Both inhibitors completely blocked the release
of IFN-, indicating that phagosomal maturation and processing
of L. acidophilus are required for the production of IFN- (*, P
0.01).
H. pylori redirects the endocytic pathway of L. acidophilus.
Since our previous experiment revealed that phagosomal process-
ing of L. acidophilus is required to trigger the release of IFN- in
macrophages, we hypothesized that H. pylori redirects the intra-
cellular processing and degradation of L. acidophilus. To deter-
mine the intracellular location of H. pylori and L. acidophilus, we
applied deconvolution microscopy and analyzed the uptake of the
bacteria with the early endosome marker EEA1 (34) and the late
endosome and lysosome marker LAMP-1 (35). Since we have
shown thatH. pylori is able to block the induction of Ifn- at a very
early stage (Fig. 2B), we added L. acidophilus NCFM to BMDMs
and analyzed the localization of the bacterium after 2 h. As can be
observed in Fig. 4A, a large proportion of intracellular L. acidophi-
lus bacteria did not colocalize with either EEA1 or LAMP-1 com-
partments. Indeed, we determined that after 2 h of incubation,
approximately only 7% and 30% of intracellular L. acidophilus
NCFM were contained within endosomal and lysosomal com-
partments, respectively (Fig. 4C). The remainder of bacteria were
not associated with either marker (*, P  0.05; **, P  0.01). In
contrast, we detected the formation of megasomes and a signifi-
cant increase in L. acidophilus colocalized in the endosomal and
lysosomal compartments (19% and 50%, respectively, after 2 h
incubation) when H. pylori was added, compared to results for
BMDMs that were stimulated with L. acidophilus alone (Fig. 4B
and C). Figure 4D presents a magnified image of L. acidophilus
localized in lysosomes (white arrow) in either the presence or
absence of H. pylori. Our results indicate a greater release of
L. acidophilus from the phagocytic compartments in the absence
of H. pylori. We suggest that the addition of H. pylori leads to an
accumulation of L. acidophilus in the endosomal and lysosomal
compartments, thereby preventing the induction of IFN- by
L. acidophilus.
DISCUSSION
In the present work, we aimed to investigate whether L. acidophi-
lus is able to modulate the inflammatory response induced by
H. pylori in bone marrow-derived macrophages (BMDMs) by ex-
amining the cellular and molecular mechanisms involved in up-
take and processing of these organisms. Whole-genome micro-
array analysis revealed that while L. acidophilus induces T-cell
recruiting chemokines (Cxcl10 and Cxcl11), proinflammatory
(IL-1 and IL-6), and Th1-skewing cytokines (IFN- and IL-12),
H. pylori predominantly induced cytokines indicative of innate
immune responses (IL-1 and IL-1) and neutrophil-recruiting
chemokines (Cxcl1, Cxcl2, and Cxcl3). Most importantly, mi-
croarray analysis revealed that when H. pylori is added to BMDMs
prestimulated with L. acidophilus, Th1-skewing cytokines induced
by L. acidophilus are strongly inhibited. Real-time PCR confirmed
that H. pylori blocks the gene expression of IFN-, IL-12, Cxcl10,
and TNF-, while it has an additive effect on the cytokine IL-1.
Thus, our results show that H. pylori prevents the production of
factors induced by L. acidophilus in macrophages that contribute
to initiating the adaptive immune response.
Interestingly, our microarray analysis also revealed that addi-
tion ofH. pylori to macrophages prestimulated with L. acidophilus
had a major impact on regulators of cytoskeletal arrangements
and actin filament depolarization, since the genes encoding Pdrx2
and Pdxp were strongly induced upon incubation with both bac-
teria. In contrast, the genes Rgs1/2, Fgd2, and Dock8, regulators of
the Rho, Rac, and Cdc42 GTPases, which are molecular switches
controlling the organization and dynamics of the actin cytoskele-
ton, were strongly suppressed. It is well established that many
bacterial pathogens regulate host trafficking pathways by the se-
lective inclusion or retention of GTPases in host cells during in-
fection and use these important cellular regulators as part of their
overall virulence strategy (36, 37). Thus, our data suggest that
H. pylori modifies GTPases in macrophages to promote bacterial
persistence in the host.
Expression of constitutively active Rac1, a member of the Rho
family of small GTPases, potentiates the activity of the H. pylori
VacA toxin in two different epithelial cell lines (SCC12F keratin-
ocytes and MDCK cells) (32). Furthermore, pinocytosis of VacA is
regulated by the Cdc42 GTPase in HeLa and gastric AGS cells (31).
Hence, we postulated that the same mechanism may be utilized in
macrophages and that the H. pylori VacA toxin is involved in the
immune-inhibitory effect observed. Indeed, the addition ofH. py-
lori vacA mutant and VacA-containing supernatant from wild-
type H. pylori 251 to L. acidophilus-stimulated BMDMs showed
that VacA is essential for the inhibition of IFN- responses.
Upon internalization in macrophages, H. pylori induces the
fusion of the individual phagosomes, resembling giant multive-
sicular bodies (13), an effect that we observed in our microscopy
(Fig. 4B). Since VacA leads to cell vacuolation in the cell mem-
branes of the late endosomal compartments in epithelial cells (33),
we used the endosomal acidification blockers chloroquine and
bafilomycin A1 to determine whether phagosomal maturation
and processing of L. acidophilus is required. Both inhibitors com-
pletely abrogated the expression of IFN- in BMDMs stimulated
with L. acidophilus, indicating that both phagocytic uptake and
phagolysosomal maturation is a prerequisite for IFN- signaling
in response to this bacterium. Our microscopy data showed that
H. pylori changes the endosomal transport of L. acidophilus from
the endosomal and lysosomal compartments in BMDMs, suggest-
ing that a specific endocytotic pathway is a key step for the induc-
tion of IFN-.
The immunosuppressive ability of H. pylori is further corrob-
orated by our microarray data. We identified that Socs3, a negative
regulator of cytokine signaling, was among the most strongly ex-
pressed genes in macrophages stimulated with H. pylori (see Ta-
ble S2 in the supplemental material). Socs3 is upregulated by sev-
eral viruses, e.g., herpes simplex virus 1 (HSV-1) (38), hepatitis
virus C (HCV) (39), influenza A virus (40), human immunodefi-
ciency virus type 1 (HIV-1) (41), severe acute respiratory syn-
drome (SARS) virus (42), and respiratory syncytial virus (RSV)
(43, 44), resulting in the inhibition of the type I interferon signal-
ing pathway. Hence, the expression of Socs3 in macrophages stim-
ulated with H. pylori might be an additional mechanism utilized
by this pathogen to suppress cytokine signaling and thereby the
activation of adaptive immunity.
We therefore suggest that the H. pylori VacA toxin causes a
redirection of the endocytic pathway in macrophages that pre-
Weiss et al.
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vents the activation of adaptive immunity, exemplified by the
Th1-skewing commensal L. acidophilus in our present study. Col-
lectively, this suppression will limit the effectiveness of L. acido-
philusNCFM as a probiotic during treatment ofH. pylori-induced
inflammation, symptoms, or eradication from the host. Although
additional investigations are required to determine how L. acido-
philus may encounter macrophages in vivo, it is plausible that this
occurs during inflammatory states. Identification of the molecular
mechanisms underlying VacA action will lead to a better under-
standing of the pathogenesis of H. pylori-associated diseases, as
they are possible targets for the treatment of H. pylori infection
and for vaccination.
FIG 4 H. pylori redirects the endocytotic pathway of L. acidophilus. Phagocytic uptake of bacteria into early endosomes and lysosomes is shown. (A) BMDMs
were exposed to red-labeled L. acidophilus NCFM for 2 h. Cells were either labeled with an EEA1 antibody for early endosomes or transfected with Lamp1-YFP
for lysosomes. (B) As per panel A, with the addition of labeled or unlabeled H. pylori 251 (magenta). Cells were prelabeled with Lysotracker DND-26 to label
lysosomes, incubated for 2 h, fixed, permeabilized, and stained with the EEA-1 antibody or anti-H. pylori serum for unlabeled H. pylori (HP). (C) Percentage of
the total L. acidophilus NCFM located in the endosomal compartment or lysosomal compartment after 1 h and 2 h of incubation (with or without H. pylori 251).
SEM are shown (*, P 0.05; **, P 0.01). (D) Magnified image of L. acidophilusNCFM (red) localized in lysosomes labeled with Lyso-DND26 (green) (2-h time
point). Yellow indicates colocalization (white arrow) of signal or L. acidophilusNCFM located within the lysosomes. Data are representative of three independent
experiments.
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MATERIALS AND METHODS
Bacterial strains, growth conditions, and preparation. The Gram-
positive lactic acid bacterium Lactobacillus acidophilus NCFM (Danisco,
Copenhagen, Denmark) was grown anaerobically overnight at 37°C in de
Man Rogosa Sharp (MRS) broth (Merck, Darmstadt, Germany). The
Gram-negative bacteriumHelicobacter pyloriwas grown on solid agar and
liquid broth as previously described (45). The following strains and mu-
tants were used: the clinical isolate Helicobacter pylori 251 (46) and the
Helicobacter pylori 251 CagPAI deletion mutant (45). The Helicobacter
pylori 251 VacA (HP0887) mutant was constructed in this study by natu-
ral transformation using the plasmid pCTB8::Km (47), a kind gift from
Tim Cover (Vanderbilt University, Nashville, TN). Confirmation of al-
lelic exchange of VacA with vacA::Km in the 251 vacA mutant was per-
formed by PCR. Heat killing of H. pylori was performed by incubating
H. pylori at 60°C for 20 min and confirming the bacteria were no longer
viable by testing their growth on solid horse blood agar as previously
described (45).
Generation of murine macrophages from bone marrow progenitor
cells. C57BL/6 mice were bred and housed under specific-pathogen-free
(SPF) conditions within the animal facility of Monash Medical Centre.
Mice were free of all Helicobacter species. All animal experiments were
approved by and performed in accordance with the Monash Medical Cen-
tre Animal Ethics Committee. Female mice were used in these studies
because they have been reported to be more susceptible to Helicobacter-
induced pathology than male mice (48).
For the generation of murine bone marrow-derived macrophages
(BMDMs), bone marrow from female 6- to 10-week-old C57BL/6 mice
was flushed out from the femur and tibia and washed in phosphate-
buffered saline (PBS). The cells were resuspended in RPMI 1640 medium
(Gibco, Life Technologies, Singapore) containing 10% (vol/vol) heat-
inactivated fetal calf serum (FCS) (Thermo Electron, VIC, Australia) sup-
plemented with 1% penicillin-streptomycin (Gibco), 1% GlutaMAX
(Gibco), and 20% of growth supernatant of L929 cells. The cells were
seeded at a concentration of 7 106 cells in 10-cm2 nontreated cell culture
plates (Nunc, Roskilde, Denmark) in 10 ml of conditioned medium and
incubated at 37°C in 5% CO2. On day 4, 10 ml of complete medium
containing 20% L929 cell-conditioned medium was added. On day 6, cells
were harvested in conditioned medium, and 1 106 cells were seeded in
24-well tissue culture plates (Nunc, Roskilde, Denmark). The next day,
the medium was removed, and 400l of fresh RPMI 1640 medium (with-
out antibiotics and FCS) was added.
Stimulation of murine bone marrow-derived macrophages with
bacteria or bacterial-free supernatants. Overnight cultures of L. acido-
philus and H. pylori were harvested by centrifugation at 1,250  g for
10 min at 4°C and washed twice in sterile PBS. Bacteria were resuspended
in RPMI 1640 medium (without FCS and antibiotics) and added (100l/
well) to the BMDMs at an MOI of 1:1 (or medium, for a final volume of
500 l/well). Bacterial-free supernatants (SN) from H. pylori 251 and the
H. pylori 251 vacA mutant were prepared as previously reported (49). In
brief,H. pylori grown for 24 h on agar plates was collected in 1 ml of sterile
distilled water, vortexed for 30 s, and incubated at room temperature for
30 min. Bacteria were removed by centrifugation, and the supernatant was
filter sterilized using a 0.2m filter. The VacA toxin contained within
the water extracts was activated using hydrochloric acid, and the pH of the
supernatant was subsequently neutralized prior to addition to BMDMs as
previously described (50). Supernatants were added to BMDMs at various
dilutions to a final volume of 500l/well. The cell cultures were incubated
at 37°C in 5% CO2. In the inhibitor experiments, BMDMs were preincu-
bated for 30 min with the endosomal acidification blockers chloroquine
(final concentration, 20 M) and bafilomycin A1 (final concentration,
25 M) prior to stimulation with L. acidophilus. Both inhibitors were
purchased from InvivoGen (San Diego, CA).
Microarray analysis. Immature murine BMDMs from three female
6-week-old C57BL/6 mice were incubated with L. acidophilus NCFM,
H. pylori 251, or H. pylori 251 added to BMDMs prestimulated with L. ac-
idophilusNCFM for 1 h. The BMDMs were harvested 5 h after addition of
H. pylori, and RNA was extracted using a Qiagen RNeasy minicolumn
with on-column DNase digestion. For each sample, 200 ng of RNA was
Cy3 labeled with a one-color low-RNA-input quick amplification kit
(Agilent). The resulting cRNA was fragmented and hybridized to Agilent
whole-mouse-genome expression microarrays (G4122F), and the slides
were washed according to the manufacturer’s instructions. Slides were
scanned immediately after washing using an Agilent DNA microarray
scanner (G2505B). Feature extraction was performed with Agilent Fea-
ture Extraction 9.5 software using default parameters excluding nonuni-
form flagged outliers. Percentile normalization and differential gene ex-
pression analysis were performed using the program GeneSpring GX 11
(Agilent Technologies).
RNA extraction and quantitative real-time PCR analysis. Murine
BMDMs were harvested and homogenized by using a QIAshredder in-
strument (Qiagen, Australia), and RNA was extracted using the RNeasy
Plus minikit (Qiagen) according to the manufacturer’s instructions. The
RNA concentration was determined with a NanoDrop instrument
(Thermo, Wilmington), and 500 ng of total RNA was reverse transcribed
with the TaqMan reverse transcription reagent kit (Applied Biosystems,
Foster City, CA) using random hexamer primers according to the manu-
facturer’s instructions. The obtained cDNA was stored in aliquots at
80°C. The following 6-carboxyfluorescein (FAM)-labeled TaqMan gene
expression assays were purchased (Applied Biosystems): Cxcl10 (assay
identifier [ID] Mm99999072_m1), IFN- (assay ID Mm00439546_s1),
IL-12b (p40) (assay ID Mm00434174_m1), TNF- (assay ID
Mm00443258_m1), IL-1 (assay, ID Mm00434228_m1), and 18S (assay,
ID 4319413E). The amplifications were prepared in a total volume of 10l
containing 1 TaqMan universal PCR master mix (Applied Biosystems)
and diluted cDNA. All PCR reactions were carried out in triplicate in
MicroAmp optical 384-well reaction plates (Applied Biosystems). The
cycling parameters were initiated by 2 min at 50°C and 10 min at 95°C,
followed by 40 cycles of 15 s at 95°C, and 60°C for 1 min using the 7900HT
fast real-time PCR system (Applied Biosystems). The amplifications were
normalized to the expression of 18S. Relative transcript levels were calcu-
lated, applying the 2CT method.
Cytokine quantification by ELISA. Protein production of IFN-was
quantified by enzyme-linked immunosorbent assay (ELISA) in the cell
culture supernatants using rat anti-mouse IFN- antibody (7F-D3; Ab-
cam, USA) followed by rabbit anti-mouse IFN- antibody (PBL Biomedi-
cals, USA) for detection. Recombinant IFN- was used as a standard
(made in-house). IL-12p40 (OptEIA kit; BD, USA) was analyzed in the
cell culture supernatants as per the manufacturer’s instructions.
Microscopy. Immature murine BMDMs were seeded at a density 2
105 cells on 12-mm coverslips (Menzelglass, Germany) in 24-well tissue
culture plates (Nunc) in a total volume of 500 l. LAMP-1 yellow fluo-
rescent protein (YFP) (concentration, 100 ng/1 105 cells; Rohan Teas-
dale, Institute for Molecular Bioscience, University of Queensland) was
transfected into half of the wells containing BMDMs using the jetPEI
macrophage in vitro DNA transfection kit (Polyplus Transfection SA,
France), according to the manufacturer’s instructions. The next day, me-
dium was removed, and 200 l of fresh RPMI 1640 medium (without
antibiotics and FCS) was added.L. acidophilusNCFM was labeled red with
the dye Dil (Vybrant cell-labeling solutions; Molecular Probes, Life Tech-
nologies, USA), and H. pylori 251 was labeled green with the dye DiO
(Vybrant cell-labeling solutions) according to the manufacturer’s proto-
col. The bacteria (or medium) were added (100l/well) to the BMDMs at
an MOI of 1:1 (total volume, 400 l). To determine the uptake of the
bacteria in the early endosomes, Dil-labeled L. acidophilus NCFM and
DiO-labeled H. pylori 251 were added to the BMDMs. The medium was
removed, the cells were rinsed with PBS, fixed in 20% Formalin for
20 min, and stored at 4°C in PBS. For antibody labeling, cells were per-
meabilized with 0.1% Triton X-100 in PBS for 10 min, blocked in 5%
bovine serum albumin (BSA)-PBS for 30 min, and labeled with the early
endosome marker EEA1 antibody (Abcam, United States). For lysosomal
Weiss et al.
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studies with coinfection, Dil-labeled L. acidophilus NCFM and unlabeled
H. pylori 251 were added to the BMDMs prelabeled with LysoTracker
green DND-26 (Molecular Probes, Life Technologies, USA) according to
the manufacturer’s instructions. Antibody labeling with purified anti-
H. pylori serum (in-house) was performed as described previously (45).
Cells were visualized by both confocal laser microscopy (Leica SP5) and
wide-field deconvolution microscopy (Deltavision core system; Applied
Precision, USA). Images are presented as a two-dimensional (2D)
maximum-intensity projection or as single-plane images.
Statistical analysis. The GraphPad Prism software program, version
4.03 (GraphPad Software, San Diego, CA), was used, and one-way analy-
sis of variance (ANOVA) and Bonferroni tests were applied (P  0.01).
The microarray data were analyzed applying one-way ANOVA with
Benjamini-Hochberg multiple testing correction (P 0.01). Colocaliza-
tion studies were performed using the built-in feature in the Bitplane
Imaris 7.5 software program with a threshold of background plus 2 stan-
dard deviations (SDs). Colocalization data were accumulated using the
GraphPad Prism program as mentioned previously, and an unpaired t test
was used to determine significance (*, P 0.05; **, P 0.01).
Microarray data accession number. The data generated in this work
have been deposited in NCBI’s Gene Expression Omnibus and are acces-
sible through GEO series accession number GSE42622.
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